Saltar al contenido
Dispositivos y mediciónEnsayo aleatorizado4 min read

Fitbit lifestyle programme gave older adults a small cognitive gain, lost after adjustment

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Effect of a wearable-based individualised multidomain lifestyle intervention on cognitive and physical function in older adults at risk of decline (INSPIOR): a single-centre, open-label, randomised controlled trial. · EClinicalMedicine · 2026 · Artículo original ↗

Idea principal

In 355 older adults in Japan, a 6-month Fitbit-based programme raised MoCA by 0.58 points versus control (95% CI 0.03-1.13; p = 0.039), but not after Holm adjustment (p = 0.12), and TMT and muscle mass showed no difference. The trial was open-label with unmasked assessors, and the gain is of uncertain clinical value.

Study design

Ensayo aleatorizado

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Multidomain lifestyle programmes are a leading way to guard against cognitive decline, but they depend on intensive face-to-face delivery that is hard to scale. The authors tested whether an automated, wearable-based programme of activity, sleep and optional nutrition prompts could change cognitive and physical function in older adults at risk.

Población y método

INSPIOR was a 6-month, single-centre, open-label randomised controlled trial in Kashiwa, Japan, in adults aged 65-92 with low body-mass index, pre-frailty, frailty or sarcopenia-related decline. Participants were assigned 1:1 (permuted blocks of four, no stratification) to the Fitbit-based intervention or an assessment-only control; allocation was not concealed and assessors were not masked. Co-primary outcomes were the Montreal Cognitive Assessment (MoCA), Trail Making Test (TMT) and skeletal muscle mass index (SMI), with no pre-specified hierarchy or multiplicity adjustment. Analyses were intention-to-treat ANCOVA with multiple imputation. Registered as UMIN000052707 and NCT06135740; funded by the University of Tokyo-NH Foods Collaborative Research Programme, Google and Mitsui Fudosan.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Between Nov 8, 2023, and Jul 31, 2024, 355 participants were randomised (178 intervention, 177 control) and all were analysed.
  2. 2
    MoCA was 0.58 points higher with the intervention (95% CI 0.03-1.13; p = 0.039; Holm-adjusted p = 0.12), a small difference the authors call of uncertain clinical significance.
  3. 3
    TMT-A differed by 0.16 s (-5.07 to 5.40; p = 0.95) and TMT-B by 5.59 s (-3.88 to 15.05; p = 0.25): no difference.
  4. 4
    SMI differed by -0.01 kg/m2 (-0.09 to 0.07; p = 0.88): no difference. Mild skin irritation and dietary-recording stress occurred; no serious adverse event was intervention-related.

Límites e incertidumbre

  1. 1
    Open-label with unconcealed allocation and unmasked assessors, so expectations could influence the results, especially the MoCA.
  2. 2
    The three co-primary outcomes had no hierarchy or multiplicity adjustment, and the one nominal result did not survive Holm adjustment.
  3. 3
    Single centre in Japan with a selected at-risk group and only 6 months of follow-up.
  4. 4
    The funders included Google, which makes the Fitbit device used, and a food company. This reading is based on the abstract only.

Relevancia práctica

A wearable-guided programme of activity, sleep and nutrition prompts for older adults produced at most a small cognitive score difference over 6 months, and no improvement in muscle mass or trail-making speed. It does not show a clear benefit. Decisions about exercise, nutrition or concerns about memory belong with a clinician.

Tus datos

The programme used a wrist wearable to track activity and sleep and prompted behavior changes. If you use similar prompts, compare your step counts, active minutes and sleep duration from the same device across weeks, and treat any change in how you feel mentally as separate from what the device says.

Cómo interpretar la evidencia

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Multidomain lifestyle programmes are the leading preventive approach to cognitive decline, but they rely on intensive face-to-face delivery that is hard to scale. We assessed whether an automated, wearable-based multidomain programme of activity, sleep, and optional nutrition prompts changed cognitive and physical function in at-risk older adults.

Methods

INSPIOR was a 6-month, single-centre, open-label, randomised controlled trial in Kashiwa, Japan. Adults aged 65-92 years with low body-mass index, pre-frailty, frailty, or sarcopenia-related decline were randomly assigned 1:1, in permuted blocks of four and without stratification, to the Fitbit-based intervention or an assessment-only control; allocation was not concealed and outcome assessors were not masked. Co-primary outcomes were the Montreal Cognitive Assessment (MoCA), Trail Making Test (TMT), and skeletal muscle mass index (SMI), with no pre-specified hierarchy or multiplicity adjustment; analyses used intention-to-treat analysis of covariance with multiple imputation. This trial was registered with UMIN-CTR, UMIN000052707, and ClinicalTrials.gov, NCT06135740.

Findings

Between Nov 8, 2023, and Jul 31, 2024, 355 participants were randomly assigned to the intervention group (n = 178) or control group (n = 177); all were analysed. Adjusted between-group differences were 0·58 MoCA points (95% CI 0·03-1·13; p = 0·039; Holm-adjusted p = 0·12), 0·16 s (-5·07 to 5·40; p = 0·95) for TMT-A, 5·59 s (-3·88 to 15·05; p = 0·25) for TMT-B, and -0·01 kg/m^(2) (-0·09 to 0·07; p = 0·88) for SMI. Mild skin irritation and dietary-recording stress occurred; no serious adverse event was intervention-related.

Interpretation

The intervention was associated with a small difference in a global cognitive screening score that did not survive multiplicity adjustment and is of uncertain clinical significance; the other two showed none. Larger, longer, masked trials are needed.

Funding

University of Tokyo-NH Foods Collaborative Research Programme, Google, Mitsui Fudosan.

Fuentes y atribución

Effect of a wearable-based individualised multidomain lifestyle intervention on cognitive and physical function in older adults at risk of decline (INSPIOR): a single-centre, open-label, randomised controlled trial.

Sakurai K, Tanaka R, Ledsam J, Shiraishi I, Kasahara H, Anzai S, Watanabe M, Funakawa M, Shimada S, Goto T, Kawabata R, Murasakino K, Kawaura T, Inamura N, Kaneta K, Kobayashi S, Nomura T, Karasawa N, Matsumoto T, Taira T, Ishiguro T, Kudo K, Thompson MJ, Kayama H, Sugawara Y, Warisawa S, Hisatsune T.

EClinicalMedicine · 2026-09-23

DOI: 10.1016/j.eclinm.2026.104212 ↗PubMed · 42831056 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →